
Bemfola - European Medicines Agency (EMA)
2014年5月16日 · Bemfola is a medicine that contains the active substance follitropin alfa. It is used to treat the following groups: women who are undergoing assisted reproductive techniques (fertility treatment) such as fertilisation. Bemfola is given to stimulate the ovaries to produce more than one egg at a time;
Bemfola: Uses, Side Effects, Benefits/Risks | Drugs.com
Bemfola is a medicine that contains the active substance follitropin alfa. It is used to treat the following groups: women who are undergoing assisted reproductive techniques (fertility treatment) such as in vitro fertilisation. Bemfola is given to stimulate …
Follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotropin (hCG) therapy. Treatment with follitropin alfa should be initiated under the supervision of a physician experienced in the treatment of fertility disorders.
- [PDF]
Bemfola® - Medsafe
Bemfola belongs to a class of hormones called gonadotrophins. FSH is necessary for the growth and development of egg cells (follicles) in women, and sperm production in men. Bemfola is an approved biosimilar to the reference product Gonal-f®. Comparability in safety, efficacy and quality between Bemfola and Gonal-f® have been established. In ...
Bemfola: Uses, Dosage, Side Effects, Food Interaction & FAQ
2025年1月7日 · Used for the treatment of female infertility, Bemfola beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Bemfola beta is the primary hormone responsible for follicular recruitment and development.
Bemfola is a medicine that contains the active substance follitropin alfa. It is used to treat the following groups: • women who are undergoing assisted reproductive techniques (fertility treatment) such as in vitro fertilisation. Bemfola is given to stimulate the ovaries to produce more than one egg at a time;
Comparison of pharmacokinetic and safety profiles between Bemfola ...
Recombinant human follicle stimulating hormone (r-hFSH) is effective and safe for controlled ovarian stimulation. Bemfola(®) (Finox AG, Burgdorf, Switzerland), a new biosimilar r-hFSH, has proven comparable non-clinical pharmacological profiles to those of the widely used Gonal-f(®) (Serono Pharma S …
Bemfola - Gedeon Richter Plc. - 药物在线
In adult women: anovulation (including polycystic ovarian disease, PCOD) in women who have been unresponsive to treatment with clomiphene citrate; stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIF...
Bemfola 450 IU/0.75 ml solution for injection in pre-filled pen
2023年10月11日 · Bemfola 450 IU/0.75 mL solution for injection in pre-filled pen: Each pre-filled pen delivers 450 IU (equivalent to 33 micrograms) in 0.75 mL. * recombinant human follicle stimulating hormone (r-hFSH) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Φάρμακο - BEMFOLA - Γαληνός
Η θυλακιοτροπίνη άλφα (follitropin alpha) είναι ωοθυλακιοτρόπος ορμόνη (γοναδοτροπίνη) που παράγεται από γενετικά επεξεργασμένα κύτταρα ωοθηκών του κινεζικού κρικητού (CHO). Στις γυναίκες η πιο σημαντική επίδραση που προέρχεται από την παρεντερική χορήγηση της FSH είναι η ανάπτυξη ωρίμων ωοθυλακίων Graaf.